HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Consumer Health Market Has Plenty To Say During Women’s History Month

Executive Summary

In addition to Opill sales starting, Kindra launches what it calls “the first-ever comprehensive vaginal health product system”; Los Angeles firm backed by Major League Baseball pitcher Justin Verlander and his wife, model Kate Upton, launches fighting bamboo pads and liners; FirmTech makes FemTech Lab 2024 lineup for help finding investors, raising capital and implementing business plan.

You may also be interested in...

CRN, Radical Science Launch Nutrition Industry’s First Award Recognizing Female Leaders

Trade group, clinical trial services firm announced annual award as to recognize a woman working with a CRN member who has shown brilliant leadership, mentorship and commitment to the industry. International life science marketing agency ramarketing announces senior appointments making more than 80% of is leadership female.

Perrigo Ships Opill To Stores, But Contraceptive Access Advocates Say It Doesn’t Deliver On Price

First US OTC daily oral contraceptive shipped to major retailers and pharmacies and will be available on shelves nationwide and online later in March. Perrigo says pre-orders for Opill are available currently from select online retailers.

Hemp Regulation Flags Raised By States Wave Tougher Compliance Cloud Over Industry

Without FDA regulatory pathway for hemp’s lawful use in supplements and food, some states are imposing more-stringent regulations while others allow sales of intoxicating ingredients not considered controlled substances as hemp derivatives.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts